Author

G. T. Jones

Observed names: G. T. JONES, G.T. Jones

Observed institutions: South Carolina Oncology Associates, Bristol-Myers Squibb (United Kingdom)

OpenAlex ID: A5079108252

Rapid microbiological pH assay for the determination of cephradine in pharmaceutical formulations and biological fluids

1985 · G.T. Jones, A.E. Beezer, et al. · Journal of Pharmaceutical and Biomedical Analysis · 7

A study of fluctuations in Escherichia coli sensitivity patterns from pigs fed a halquinol supplemented diet

1981 · R. F. COSGROVE, T. C. FORSTER, et al. · Journal of Veterinary Pharmacology and Therapeutics · 5

Lenalidomide in combination with gemcitabine in patients with untreated metastatic carcinoma of the pancreas: A Sarah Cannon Research Institute phase II trial.

2011 · H. Arkenau, J. R. Infante, et al. · Journal of Clinical Oncology · 3

Bone levels of cephradine and cefuroxime after intravenous administration in patients undergoing total hip replacement

1987 · T. J. Cain, G. T. Jones, et al. · International Orthopaedics · 2

A phase II study to evaluate the feasibility of bi-weekly docetaxel followed by bi-weekly doxorubicin and cyclophosphamide as adjuvant therapy for operable breast cancer (T-AC)

2004 · R. Lambert-Falls, M. Ackerman, et al. · Journal of Clinical Oncology · 1

Works count: 5

Citation count: 18

H-index: 3

I10-index: